NCT03703427 2018-10-12Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative ChemotherapyShandong Cancer Hospital and InstitutePhase 2 Unknown200 enrolled